17 unknown. 17 Phase 2, 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 17 | Unknown 17 |
| Phase 1 | 2 | Unknown 2 |
Follow titanium silicide: new trials by email Literature Review of titanium silicide trials Research Report on titanium silicide
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Perioperative Leucovorin, Oxaliplatin, Docetaxel and S-1 (LOTS) For Locally Advanced Gastric or Gastroesophageal Junction Cancer leucovorin, oxaliplatin, docetaxel, S-1 - Gastric Cancer, Gastric Adenocarcinoma | Phase 2 | Unknown | National Cheng-Kung University Hospital | 58 | 2021-12-10 | 2023-11-15 |
| S-1, Irinotecan, and Oxaliplatin in Locally-Advanced Pancreatic Cancer Tegafur-gimeracil-oteracil potassium, Oxaliplatin, Irinotecan - Pancreatic Ductal Adenocarcinoma | Phase 2 | Unknown | National Taiwan University Hospital | 35 | 2017-11-01 | 2017-10-20 |
| Docetaxel and S-1 Combination Therapy as Second-line Treatment for Advanced Gastric Cancer Docetaxel, S-1 - Advanced Gastric Cancer | Phase 2 | Unknown | Fujian Cancer Hospital | 47 | 2017-06-01 | 2017-05-08 |
| Adjuvant Gemcitabine Versus Gemcitabine With Chemoradiation in Pancreatic Adenocarcinoma With R1 Resection and/or Positive Lymph Nodes Gemcitabine, TS-1 with radiation - Pancreatic Neoplasms | Phase 2 | Unknown | Peking Union Medical College Hospital | 110 | 2016-03-01 | 2016-04-28 |
| SOX Versus XELOX for Patients With Peritoneal Metastasis of Colorectal Cancer SOX, XELOX - Colorectal Neoplasm | Phase 2 | Unknown | The First People's Hospital of Changzhou | 60 | 2013-01-01 | 2016-08-19 |
| Cisplatin,Docetaxel and S-1 for Advanced Gastric and Gastroesophageal Junction Cancer Docetaxel, Cisplatin, S-1 - Gastric Cancer, Gastroesophageal Junction Cancer | Phase 2 | Unknown | Chinese Academy of Medical Sciences | 40 | 2012-09-01 | 2012-12-12 |
| Study of DPD for Predicting Efficacy and Safety to S-1 Plus Oxaliplatin in Gastrointestinal Cancer S-1 plus oxaliplatin - Gastrointestinal Cancer | Phase 2 | Unknown | Xijing Hospital | 200 | 2012-03-01 | 2012-05-31 |
| Study of TS-1 as 2nd Line Treatment in Patients With Advanced Metastatic Breast Cancer Tegafur Gimeracil Oteracil Potassium Capsule - Breast Cancer | Phase 2 | Unknown | Chinese Academy of Medical Sciences | 30 | 2011-12-01 | 2013-03-15 |
| Docetaxel and S-1 for Advanced Esophageal Cancer DS (docetaxel+S-1) - Esophageal Neoplasms | Phase 2 | Unknown | Hallym University Medical Center | 37 | 2011-11-01 | 2017-08-23 |
| S-1/LV One Week on and One Week Off Regimen in Advanced Hepatocellular Carcinoma (HCC) S-1 combined with Leucovorin - Carcinoma, Liver Diseases | Phase 2 | Unknown | Second Military Medical University | 32 | 2011-11-01 | 2012-02-15 |
| S-1 Versus S-1 Plus Cisplatin as an Adjuvant Chemotherapy to Treat Gastric Cancer S-1, S-1 plus cisplatin - Gastric Cancer | Phase 2 | Unknown | Kyungpook National University Hospital | 218 | 2011-09-01 | 2012-01-05 |
| SOX as Adjuvant Chemotherapy for Resectable Gastric Cancer s1, Oxaliplatin - Gastric Cancer | Phase 1 / Phase 2 | Unknown | Chinese Academy of Medical Sciences | 71 | 2011-06-01 | 2016-06-14 |
| A Phaseâ…¡ Study: SOX vs SP in Adjuvant Chemotherapy After D2 Surgery S-1, oxaliplatin, cisplatin - Gastric Cancer | Phase 2 | Unknown | Peking University | 160 | 2011-04-01 | 2015-05-19 |
| A Study of Genomic-guided 'Standard-of-care' Chemotherapy for in Advanced Gastric Cancer Patients TS-1 with cisplatin, TS-1 with oxaliplatin - Recurrent Gastric Cancer | Phase 2 | Unknown | National University Hospital, Singapore | 90 | 2010-07-01 | 2016-06-22 |
| Attenuated SOX as First-line Treatment in Elderly Patients With Relapsed or Metastatic Gastric Cancer S-1 (TS-1) and Oxaliplatin (Oxalitin) - Elderly, S-1 | Phase 2 | Unknown | Soonchunhyang University Hospital | 36 | 2009-08-01 | 2009-08-18 |
| A Study of TS-1 Plus Irinotecan and Cisplatin (IP) for Patients With Stage IIIB/IV Non Small Cell Lung Cancer (NSCLC) Irinotecan, Cisplatin, TS-1 (S-1) - Advanced Non-Small Cell Lung Cancer | Phase 1 / Phase 2 | Unknown | National Cancer Center, Korea | 74 | 2008-10-01 | 2010-10-25 |
| Phase II Study of Oral S-1 Plus Irinotecan (IRIS) in Patients With Advanced Colorectal Cancer Campto, Topotesin, TS-1 - Colorectal Cancer | Phase 2 | Unknown | Hokkaido Gastrointestinal Cancer Study Group | 40 | 2004-01-01 | 2007-11-01 |
Stomach Neoplasms (7) · Colorectal Neoplasms (2) · Neoplasm Metastasis (2) · Breast Neoplasms (1) · Carcinoma (1) · Carcinoma, Hepatocellular (1) · Carcinoma, Non-Small-Cell Lung (1) · Esophageal Neoplasms (1) · Gastrointestinal Neoplasms (1) · Liver Diseases (1) · Pancreatic Neoplasms (1) · Recurrence (1)
Chinese Academy of Medical Sciences (3) · Fujian Cancer Hospital (1) · Hallym University Medical Center (1) · Hokkaido Gastrointestinal Cancer Study Group (1) · Kyungpook National University Hospital (1) · National Cancer Center, Korea (1) · National Cheng-Kung University Hospital (1) · National Taiwan University Hospital (1) · National University Hospital, Singapore (1) · Peking Union Medical College Hospital (1) · Peking University (1) · Second Military Medical University (1) · Soonchunhyang University Hospital (1) · The First People's Hospital of Changzhou (1) · Xijing Hospital (1)
China (9) · South Korea (3) · Japan (1) · Singapore (1) · Taiwan (1)
Aiping Zhou, M.D (1) · Binghe Xu, MD, PhD (1) · Changping Wu, M.D. (1) · Chia Jui Yen, M.D., Ph.D. (1) · Dae Young Zang, MD, PhD (1) · Heung Tae Kim, M.D. (1) · I Shu Chen, M.D. (1) · Li Yuan Bai, M.D., Ph.D. (1) · Lin Yang, MD (1) · Ming Huang Chen, M.D., Ph.D. (1) · Rongbo Lin, MD (1) · Sang-Cheol Lee, M.D. (1) · Wansik Yu, Professor (1) · Wei Peng Yong, MRCP, MB ChB (1)
PMID 16822992, PMID 21444866, PMID 29743043, PMID 30982686, PMID 31765987